terazosin and its Impurities
A quinazoline derivative which is an alpha-1-selective adrenoceptor blocking agent used on once-a-day basis for therapy of mild-to-moderate hypertension. Terazosin is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). Reference standards of Terazosin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.


[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl][(5S)-tetrahydro-5-methyl-2-furanyl]methanone-d8
[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl][(5S)-tetrahydro-5-methyl-2-furanyl]methanone-d8
Catalogue No.:PA STI 088227
CAS :
2714488-83-0
Molecular Formula : C20H19D8N5O4
Molecular Weight : 409.51


1-(4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl-2,2,3,3,5,5,6,6-d8)-2-hydroxypentan-1-one
1-(4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl-2,2,3,3,5,5,6,6-d8)-2-hydroxypentan-1-one
Catalogue No.:PA STI 088228
CAS :
2714408-48-5
Molecular Formula : C19H19D8N5O4
Molecular Weight : 397.50


(4-(4-Amino-6-hydroxy-7-methoxyquinazolin-2-yl)piperazin-1-yl-2,2,3,3,5,5,6,6-d8)(tetrahydrofuran-2-yl)methanone
(4-(4-Amino-6-hydroxy-7-methoxyquinazolin-2-yl)piperazin-1-yl-2,2,3,3,5,5,6,6-d8)(tetrahydrofuran-2-yl)methanone
Catalogue No.:PA STI 088229
CAS :
2714485-00-2
Molecular Formula : C18H15D8N5O4
Molecular Weight : 381.46


(4-(4-Amino-7-hydroxy-6-methoxyquinazolin-2-yl)piperazin-1-yl-2,2,3,3,5,5,6,6-d8)(tetrahydrofuran-2-yl)methanone
(4-(4-Amino-7-hydroxy-6-methoxyquinazolin-2-yl)piperazin-1-yl-2,2,3,3,5,5,6,6-d8)(tetrahydrofuran-2-yl)methanone
Catalogue No.:PA STI 088230
CAS :
2714430-62-1
Molecular Formula : C18H15D8N5O4
Molecular Weight : 381.46